Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Expert Committees
Advisory groups
Publications
All →
28 August 2025
Good practices for blood establishments
Blood transfusion is a vital component of modern health care and can be life-saving in many clinical situations. However, it is not without risks, including...
14 May 2025
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety:...
WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual...
23 April 2025
Guidance on implementing patient blood management to improve global blood health status
Incorporating expertise from peers working in countries where health care faces extreme resource constraints, attention is paid to how PBM processes...
16 April 2025
WHO Drug Information - Volume 39, No. 1
The first issue of volume 39 for 2025 includes:Consultation Documents: - "Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus)"- "Aminosalicylate...
Journal articles
New WHO INN for cell-based and gene-based substances: timing, usage, and simplicity
The Lancet, Correspondence| Volume 404, Issue 10460, P1302-1303,October 05, 2024
Role of HIV self-testing in strengthening HIV prevention services
The Lancet HIV, September 2024
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
Pharmaceutics. 2022 Feb 22;14(3):473
